MRNA--

mrna fda deadline vaccine flu shot outlook

$MRNA the FDA has a deadline of Aug. 5 to make a call on the vaccine. While they don't have to follow the committee's advice, they usually do so investors can feel hopeful about the outcome. This means Moderna's flu shot is set to hit the market for the 2026-2027 flu season.

Comments



No comments

No comments yet

Disclaimer: The above is a summary showing certain market information. Ainvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing, All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market.Report an Issue